ScreenerHero

BIAF bioAffinity Technologies, Inc.

NAS · US · Healthcare · Diagnostics & Research · bioaffinitytech.com
6.160USD+1.65%Mkt Cap: 7.19M $P/E: —

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United Sta…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$244.79BUSDP/E 36.7
DHR
Danaher Corporation
$153.60BUSDP/E 38.9
NTRA
Natera, Inc.
$57.02BUSD
LONN
Lonza Group AG
$46.01BUSDP/E 38.3
A
Agilent Technologies, Inc.
$47.67BUSDP/E 33.4
WAT
Waters Corporation
$42.81BUSDP/E 110.4
IQV
IQVIA Holdings Inc.
$42.48BUSDP/E 32.1
ILMN
Illumina, Inc.
$40.43BUSDP/E 50.0
IDXX
IDEXX Laboratories, Inc.
$39.97BUSDP/E 35.6
MTD
Mettler-Toledo International Inc.
$30.73BUSDP/E 34.6
LH
Labcorp Holdings Inc.
$25.30BUSDP/E 25.8
DGX
Quest Diagnostics Incorporated
$25.06BUSDP/E 24.1
GH
Guardant Health, Inc.
$22.59BUSD
RVTY
Revvity, Inc.
$17.14BUSDP/E 73.5
MEDP
Medpace Holdings, Inc.
$16.87BUSDP/E 35.5
ERF
Eurofins Scientific SE
$14.23BUSDP/E 26.6
CRL
Charles River Laboratories International, Inc.
$14.34BUSD
ICLR
ICON Public Limited Company
$12.66BUSDP/E 172.7
BIM
bioMérieux S.A.
$10.35BUSDP/E 20.7
QGEN
Qiagen N.V.
$9.25BUSDP/E 22.7

Key Statistics

Company
Market Cap7.19M USD
Enterprise Value2.28M USD
Revenue (TTM)5.90M USD
Gross Profit1.88M USD
Net Income (TTM)-14.91M USD
Revenue/Share23.20 USD
Last Price6.160 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees57
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.10
PEG—
EV/EBITDA-0.19
EV/Revenue0.39
P/S1.20
P/B0.73
EPS (TTM)-107.57
EPS (Forward)-0.60
52W Range
4.8701% of range109.35
52W High109.35 USD
52W Low4.870 USD
Profitability
Gross Margin30.80%
Oper. Margin-220.77%
EBITDA Margin-202.82%
Profit Margin-244.10%
ROE-204.87%
ROA-136.03%
Growth
Revenue Growth19.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.33M USD
CapEx (TTM)60.57K USD
FCF Margin-117.09%
FCF Yield-96.14%
Net Debt-994.71K USD
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity0.16
Current Ratio1.44
Quick Ratio1.24
Book Value/Sh8.34 USD
Cash/Share4.50 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateAug 24, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.17M
Float532.26K
Insiders0.82%
Institutions5.56%
Short Interest
Short Ratio0.0d
Short % Float6.13%
Short % Out.6.10%
Shares Short71.17K
Short (prev mo.)13.04K
Technical
SMA 507.633 (-19.3%)
SMA 20020.66 (-70.2%)
Beta-1.25
S&P 52W Chg16.45%
Avg Vol (30d)5.27M
Avg Vol (10d)266.94K
Technical Indicators
RSI (14)42.8
MACD-0.7110
MACD Signal-0.5562
MACD Hist.-0.1548
BB Upper10.20 USD
BB Middle7.595 USD
BB Lower4.989 USD
BB Width68.64%
ATR (14)1.389 USD
Vol Ratio (20d)0.04x